Burkina Faso vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Georgia
100.0%
in 2024
Burkina Faso rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Georgia
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 2 times across 20 shared years of data; in 2005 it was Georgia ahead.
Burkina Faso ranks 1st and Georgia ranks 1st of 144 countries.
Georgia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.6% | 71.8% | 27.2% | Georgia |
| 2010s | 79.5% | 89.8% | 10.3% | Georgia |
| 2020s | 94.2% | 96.6% | 2.4% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Georgia?
- Burkina Faso, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Georgia?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Georgia?
- 20 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.